Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.31 CAD | +24.00% |
|
+24.00% | +34.78% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Steven Saviuk
CEO | Chief Executive Officer | 65 | 86-09-30 |
Helen Saviuk
DFI | Director of Finance/CFO | 71 | 10-03-28 |
Guy-Paul Allard
LAW | General Counsel | 56 | 16-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Tinmouth
BRD | Director/Board Member | - | 04-04-27 |
Steven Saviuk
CEO | Chief Executive Officer | 65 | 86-09-30 |
Helen Saviuk
DFI | Director of Finance/CFO | 71 | 10-03-28 |
Marc Bélair
BRD | Director/Board Member | - | 20-04-02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 12,661,276 | 4,880,389 ( 38.55 %) | 0 | 38.55 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
VALEO PHARMA INC. 27.62% | 27,247,877 | 27.62% | 1,934,599 $ |
CHITOGENX INC. 6.35% | 5,275,392 | 6.35% | 158,262 $ |
Company contact information
Manitex Capital, Inc.
16667 Hymus Boulevard
H9H 4R9, Kirkland
+
![address Manitex Capital Inc.(MNX)](https://cdn.zonebourse.com/static/address/49477059.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+34.78% | 2.88M | |
+57.48% | 827B | |
-7.18% | 350B | |
+15.37% | 319B | |
+7.45% | 294B | |
+14.30% | 240B | |
+15.29% | 221B | |
+0.94% | 219B | |
+8.14% | 167B | |
-2.99% | 158B |
- Stock Market
- Equities
- MNX Stock
- Company Manitex Capital Inc.